期刊文献+

隔盐灸治疗良性前列腺增生症50例临床疗效观察 被引量:16

Clinical Curative Observation of Applying Moxibustion on Salt in the Treatment of 50 Cases of Benign Prostatic Hyperplasia
下载PDF
导出
摘要 目的:观察隔盐灸治疗良性前列腺增生症(BPH)的疗效和安全性。方法:将100例BPH随机分成治疗和对照两组,治疗组患者采用隔盐灸治疗,每日1次;对照组患者非那雄胺5mg,每日1次,用药期间不做其他治疗。检测和评判连续3月的临床疗效。结果:治疗组总有效率78.0%,总显效率42.0%;对照组总有效率70.0%,总显效率为20.0%,差异有显著性(P<0.05);治疗组在改善患者的主要症状、降低I-PSS分值和改善患者生活质量指数等方面,疗效优于对照组(P<0.05);治疗组在提高最大尿流率、降低残余尿量疗效优于对照组(P<0.05)。两组在前列腺体积、前列腺特异性抗原PSA下降幅度方面无显著差异(P>0.05);两组肝、肾功,血、尿常规,血压,心电图等指标均未见有明显的变化。结论:隔盐灸对BPH具有显著的疗效,且安全无明显毒副反应。 Objective: To observe the efficacy and safety of using moxibustion onsah in the treatment of benign prostatic hy- perplasia (BPH). Methods: 100patients with BPH were randomly divided into two groups. Patients in curative group (n=50) were given moxibustion on salt, and patients in controlled group (n = 50) were given orally Finasteride Tablets (1 piece, qd) re- spectively for 3months. And then the international prostatic symptom score, life quality index, prostate volume, maximum flow rate of urine and residual urine in bladder etc. were detected before and after treatment in the two groups. Results : The total ef- fective rate and the total significant effective rate were 78. 0% and 42. 0% respectively in the curative group, while being 70. 0% and 20. 0% in the controlled group respectively, in which there was significant difference between the two groups (P〈O. 05). The curative group was notably better than the controlled group in the aspects of improving the main symptoms, raising maximum flow rate of urine, reducing residual urine volume in bladder, prostatic specific antigen (PSA) in serum and the value of Interna- tional prostate symptom score (I-PSS) in patients (P〈0. 05). There were no significant differences in the liver and kidney function, blood and urinary routine, blood pressure, Electro-Cardio-Gram (ECG). Conclusion: The therapeutic effect of moxi- bustion on salt on BPH was satisfactory with no serious toxicity and side effects.
出处 《四川中医》 2016年第1期175-177,共3页 Journal of Sichuan of Traditional Chinese Medicine
基金 上海市中医药能力提升工程 上海市中医药特色项目(项目编号:Shjczyynlts-sqzyyts-34)
关键词 良性前列腺增生症(BPH) 隔盐灸 临床观察 Benign prostatic hyperplasia (BPH) Moxibustion on salt Clinical study
  • 相关文献

参考文献6

二级参考文献14

  • 1叶科贵.辨证论治前列腺增生症67例[J].河南中医,2006,26(7):43-44. 被引量:7
  • 2国家中医药管理局.中医病证诊断疗效标准[S].南京:南京大学出版社,2008:38. 被引量:9
  • 3Kyprianou N, Tu H C, Jacobs S C. Apoptotic versus proliferatie activities in human BPH[J]. Hum Pathol, 1996, 27: 668-675. 被引量:1
  • 4Gormley G J, Stoner E, Bruskewitz R C, et al. The effect of finasteride in men with benign prostatic hyperplasia[J]. N Engl J Med,1992,327: 1185-1191. 被引量:1
  • 5Sutton M T, Yingling M. Finasteride targets prostate vascularity by inducing apoptosis and inhibiting cell adhesion of benign and malignant prostate cells [J]. Prostate, 2006,66(11):1194-1202. 被引量:1
  • 6Saez C, Gonzdlez-Baena A C, Japon M A, et al. Regressive changes in finasteride-treated human hyperplastic prostates correlate with an upregulation of TGF-beta receptor expression [J].Prostate, 1998, 37 (2): 84 -90. 被引量:1
  • 7Glassman D T,Chon J K,Borkowski A,et al. Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia[J]. Prostate, 2001, 46 (1): 45-51. 被引量:1
  • 8Bozec A, Ruffion A, Decaussin M, et al. Activation of caspases-3, -6 ,and-9 during finasteride treatment of benign prostatic hyperplasia [J].J Clin Endocrinol Metab, 2005, 90 (1): 17-25. 被引量:1
  • 9Erdogru T,Ciftcioglu M A, Emreoglu I, et al. Apoptotic and proliferative index after Alpha1 adrenoceptor antagonist and/or finasteride treatment in benign prostatic hyperplasia[J]. Urologia Internationalis, 2002,69 (4):287-292. 被引量:1
  • 10王界宇,王学明.野菊花栓联合前列安栓治疗慢性前列腺炎[J].中国临床医生杂志,2007,35(12):35-37. 被引量:13

共引文献19

同被引文献284

引证文献16

二级引证文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部